Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. US tariffs trigger 123% Singapore pharma output surge 2. Australia commits $80.33m to 60 medical research projects 3. Shape the future of sustainable medicine with NUS’ programmes 4. Gleneagles scales Johor operations as medical tourism jumps 66% 5. Tam Anh group launches $95m university in VietnamResource Center
Read Here
Advertise
Sign Up
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
